Protocol summary

Summary
This study will be done in triple blind method with the target of determining the effect of urtica dioica on menorrhagia. Inclusion criteria are: Age 15 to 45 years; Body Mass Index 18.5 to 29.9; having regular menstrual periods; Being affected by menorrhagia; distinguished by using pictorial blood loss assessment chart and exclusion criteria are: allergy to urtica dioica; Having an special disease; pregnancy or deciding to be pregnant in three future month; berest feeding; dont follow the exact priscribed curing method and patient,s tendency to going out of study. the comunity of study includes all of the women affected by menorrhagia which refer to gynecological centeres related to medical science university of Mazandaran in 2011. 90 patients will be allocated into two groups by chance, control group or intervention group and then mefenamic acid and urtica dioica will be prescribed to intervention group and mefenamic acid and placebo of urtica dioica will be prescribed to control group for two cycle. the number of days and amount of bleeding will be checked inside and between groups before intervention and after the first and second cycle of intervention.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT201111254529N3
Registration date: 2012-05-17, 1391/02/28
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2012-05-17, 1391/02/28
Registrant information
Name
Nourossadat Kariman
Name of organization / entity
Shaheed Beheshti University Of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 21 8888 3133
Email address
n_kariman@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Shahid Beheshty University Of Medical Science; International Part.
Expected recruitment start date
2012-01-05, 1390/10/15
Expected recruitment end date
2012-07-05, 1391/04/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparing the effect of hydroalchoholic extract of Urtica Dioica with mefenamic acid on Menorrhagia in referring women to gynecological centeres related to Mazandaran Medical Sience university on 2011.
Public title
Comparing the effect of Urtica Dioica with mefenamic acid on heavy menstrual bleeding.
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: Age15 to 45 years; Body Mass Index 18.5 to 29.9; Being affected by menorrhagia, distinguished by using pictorial blood loss assessment chart. exclusion criteria: Having an special disease; pregnancy or deciding to be pregnant in three future month; berestfeeding; allergy to urtica dioica; dont follow the exact priscribed curing method; patient,s tendency to going out of study.
Age
From 15 years old to 45 years old
Gender
Female
Phase
3
Groups that have been masked
No information
Sample size
Target sample size: 90
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Triple blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
shahid beheshti university of medical science - international part
Street address
valiasr Street-shahid abbaspur Street ( tavanir ) -hemmat bridge- 19
City
Thran
Postal code
1434875451
Approval date
2011-12-13, 1390/09/22
Ethics committee reference number
3739/116

Health conditions studied

1

Description of health condition studied
Menorrhagia
ICD-10 code
N92.0
ICD-10 code description
خونریزی شدید قاعدگی با سیکلهای منظم.

Primary outcomes

1

Description
Number of days of bleeding in menstruation.
Timepoint
Befor, one month and then two month after intervention.
Method of measurement
By using pictorial blood loss assessmant chart.

2

Description
Amount of menstrual Bleeding.
Timepoint
Befor, one month and two month after intervention
Method of measurement
By using pictorial blood loss assessmant chart.

Secondary outcomes

1

Description
side effects of priscribed drugs
Timepoint
During and after first and second month of using drugs.
Method of measurement
By using the chart of daily using of drugs.

Intervention groups

1

Description
mefenamic acid cap 500 mg q8hr and Urtica dioica cap 1 mg q12hr, from the first day of menstrustion, for 7 days will be prescribed to intervention group.
Category
Treatment - Drugs

2

Description
mefenamic acid cap 500 mg q8hr and placebo of Urtica dioica cap 1 mg q12hr, from the first day of menstrustion, for 7 days will be prescribed to placebo group.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Khomeiny Hospital Of Sari.
Full name of responsible person
Atefe Sortiji, MSc Midwifery Steudent.
Street address
Imam khomeiny Hospital, Amir Mazandarani street.
City
Sari

2

Recruitment center
Name of recruitment center
Razi Hospital Of Ghaemshahr
Full name of responsible person
Atefe sourtiji, MSc Midwifery Steudent
Street address
Razi Hospital, Yusef Reza Street, Ghaemshahr
City
Sari

3

Recruitment center
Name of recruitment center
Imam Ali Hospital Of Amol
Full name of responsible person
Atefe sourtiji, MSc Midwifery steudent.
Street address
Imam Ali Hospital, Fajr Square, Sheykh Fazlollah Nouri Boulevard , Amol
City
Sari

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
International part Of Shahid Beheshti University of Medical Science
Full name of responsible person
Dr Ali Haery
Street address
Number19, International part Of Shahid Beheshti University of Medical Science, Hemmat Bridge, Shahid Abbaspoour Street ( Tavanir ), Valiasr Street
City
Tehran
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
International part Of Shahid Beheshti University of Medical Science
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
International Part Of Shahid Beheshti University of Medical Science
Full name of responsible person
Atefe Sourtiji
Position
MSc Midwifery Steudent of Shahid Beheshti University of Medical Science, International Part
Other areas of specialty/work
Street address
Number 19, International Part Of Shahid Beheshti University of Medical Science, Hemmat Bridge, Shahid Abbaspour Street ( Tavanir ), Valiasr Street.
City
Tehran
Postal code
1434875451
Phone
+98 21886491756
Fax
+98 88649181
Email
ib@sbmu.ac.ir
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti Universityof Midwifery and Nursing
Full name of responsible person
Mrs. Nourossadat Kariman
Position
Msc of Midwifery
Other areas of specialty/work
Street address
Shahid Beheshti University, Bisection Valiasr Street, Niaysh Street.
City
Tehran
Postal code
Phone
+98 21 8820 2512
Fax
Email
n_kariman@yahoo.com
Web page address
www.sbmu.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
International Part of Shahid Beheshti University of Medical Science
Full name of responsible person
Atefe Sourtiji
Position
MSc Midwifery Steudent
Other areas of specialty/work
Street address
Number19 ,International Part of Shahid Beheshti University of Medical Science, Hemmat bridge, Shahid Abbaspour Street ( Tavanir ), valiasr street.
City
Tehran
Postal code
1434875451
Phone
+98 21886491756
Fax
+98 88649181
Email
ib@sbmu.ac.ir
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...